Interactions among microorganisms open up a new world for anti-infectious therapy

被引:6
|
作者
Zhang, Yejia [1 ]
Zhang, Hanchi [1 ,2 ]
Xu, Tian [1 ]
Zeng, Lingbing [1 ,2 ]
Liu, Fadi [3 ]
Huang, Xiaotian [1 ,4 ]
Liu, Qiong [1 ,4 ]
机构
[1] Nanchang Univ, Jiangxi Med Coll, Sch Med, Dept Med Microbiol, Nanchang, Peoples R China
[2] Nanchang Univ, Clin Med Coll 1, Nanchang, Peoples R China
[3] Childrens Hosp Jiangxi Prov, Dept Clin Lab, Nanchang, Peoples R China
[4] Nanchang Univ, Jiangxi Med Coll, Sch Med, Dept Med Microbiol, Nanchang 330006, Peoples R China
基金
中国国家自然科学基金;
关键词
bacteria; fungi; interaction; microbiota; virus; BIOSYNTHETIC GENE CLUSTERS; CANDIDA-ALBICANS; STREPTOCOCCUS-MUTANS; ATOPIC-DERMATITIS; BIOFILM FORMATION; NATURAL-PRODUCTS; VIRUS INCREASES; BACTERIAL; MICROBIOTA; INFLUENZA;
D O I
10.1111/febs.16705
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The human microbiome, containing bacteria, fungi, and viruses, is a community that coexists peacefully with humans most of the time, but with the potential to cause disease under certain conditions. When the environment changes or certain stimuli are received, microbes may interact with each other, causing or increasing the severity of disease in a host. With the appropriate methods, we can make these microbiota work for us, creating new applications for human health. This review discusses the wide range of interactions between microorganisms that result in an increase in susceptibility to, severity of, and mortality of diseases, and also briefly introduces how microorganisms interact with each other directly or indirectly. The study of microbial interactions and their mechanisms has revealed a new world of treatments for infectious disease. The regulation of the balance between intestinal flora, the correct application of probiotics, and the development of effective drugs by symbiosis all demonstrate the great contributions of the microbiota to human health and its powerful potential value. Consequently, the study of interactions between microorganisms plays an essential role in identifying the causes of diseases and the development of treatments.
引用
收藏
页码:1615 / 1631
页数:17
相关论文
共 50 条
  • [1] Immunoglobulins in anti-infectious therapy
    Berthelot, P
    Guglielminotti, C
    Fresard, A
    Zeni, F
    Lucht, F
    MEDECINE ET MALADIES INFECTIEUSES, 1998, 28 (05): : 414 - 417
  • [2] Lectins: targets for new anti-infectious
    Varrot, A.
    FEBS JOURNAL, 2014, 281 : 56 - 56
  • [3] Special features of the anti-infectious Therapy in immunodeficiency
    Schoefer, H.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2011, 9 : 104 - 104
  • [4] Infectious diseases, anti-infectious agents, epidemiology and antibiotic therapy
    Bergogne-Bérézin, E
    Muller-Serieys, C
    PRESSE MEDICALE, 1998, 27 (06): : 264 - 265
  • [5] Magnetite Nanostructures as Novel Strategies for Anti-Infectious Therapy
    Liakos, Ioannis
    Grumezescu, Alexandru Mihai
    Holban, Alina Maria
    MOLECULES, 2014, 19 (08): : 12710 - 12726
  • [6] ABOUT A NEW BACTERICIDE URINARY ANTI-INFECTIOUS - THE FLUMEQUINE
    VIVILLE, C
    JOURNAL DE MEDECINE DE STRASBOURG, 1981, 12 (05): : 333 - 334
  • [7] New prospects for mucosal immunization: anti-infectious and anti-immunopathologic vaccines
    Holmgren, J
    Czerkinsky, C
    Eriksson, K
    Fredriksson, M
    Johansson, EL
    Lebens, M
    Lindblad, M
    Mielcarek, N
    Rask, C
    Rudin, A
    Sun, JB
    10TH INTERNATIONAL CONGRESS ON IMMUNOLOGY, VOLS 1 AND 2, 1998, : 1321 - 1325
  • [8] C-REACTIVE PROTEIN AS A STANDARD OF EFFICIENCY IN ANTI-INFECTIOUS THERAPY
    MATESANZ, JL
    SANTOS, F
    NUNO, F
    DIEGUEZ, MA
    MALAGA, S
    CRESPO, M
    ANALES ESPANOLES DE PEDIATRIA, 1980, 13 (06): : 507 - 512
  • [9] ANTI-INFECTIOUS THERAPY - WHICH ANTIBACTERIAL THERAPY IS RECOMMENDABLE IN CANCER-PATIENTS WITH GRANULOCYTOPENIA
    SPORS, S
    GROSS, R
    MEDIZINISCHE WELT, 1982, 33 (16): : 573 - 574
  • [10] Anti-infectious treatment in critical patients with MODS - approved and new antibiotics
    Kern, Peter
    ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH, 2006, 56 (11): : 787 - 788